SCHEMBL3515735

SCHEMBL3515735

CCCCCc1cc(O)cc(O)c1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.58
TYR P14679 3/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
CYP3A4 P08684 2/20 0.58
MAPT P10636 2/20 0.58
TP53 P04637 1/20 0.58
ALOX15 P16050 1/20 0.58
TSHR P16473 1/20 0.58
HTT P42858 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
PTGS2 P35354 6/20 0.52
RBP1 P09455 1/20 0.48
PTGES O14684 1/20 0.48
TOP2A P11388 1/20 0.48
PTPN1 P18031 2/20 0.47
GPR55 Q9Y2T6 1/20 0.46
PTPN11 Q06124 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29424247 1.00 ALOX5 (0.58) ALOX5TYRMEN1KMT2ACYP3A4
SCHEMBL19327407 0.98 ALOX5 (0.61) ALOX5TYRMEN1KMT2ACYP3A4
SCHEMBL18152915 0.94 TYR (0.58) ALOX5TYRMEN1KMT2ACYP3A4
SCHEMBL5702284 0.86 PTPN1 (0.56) ALOX5TYRMEN1KMT2ACYP3A4
SCHEMBL62286 0.84 TYR (0.53) ALOX5TYRMEN1KMT2ACYP3A4
SCHEMBL13862945 0.82 ALOX5 (0.59) ALOX5TYRMEN1KMT2ACYP3A4
SCHEMBL16431532 0.81 ALOX5 (0.65) ALOX5TYRMEN1KMT2ACYP3A4
SCHEMBL3204289 0.81 ALOX5 (0.65) ALOX5TYRMEN1KMT2ACYP3A4
SCHEMBL17867241 0.81 ALOX5 (0.65) ALOX5TYRMEN1KMT2ACYP3A4
SCHEMBL31544904 0.81 TYR (0.61) ALOX5TYRMEN1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120161499-A H-3 online monitoring system and H-3 online monitoring method 阳江核电有限公司 2025-06-17 CN disclosed
US-12196074-B2 Systems and methods for sand ingress prediction for subterranean wellbores Lytt Limited (GB) 2025-01-14 US disclosed
US-20230416789-A1 OLIVETOLIC ACID CYCLASE VARIANTS WITH IMPROVED ACTIVITY FOR USE IN PRODUCTION OF PHYTOCANNABINOIDS HYASYNTH BIOLOGICALS INC. (CA) 2023-12-28 US disclosed
EP-4247956-A1 OLIVETOLIC ACID CYCLASE VARIANTS WITH IMPROVED ACTIVITY FOR USE IN PRODUCTION OF PHYTOCANNABINOIDS Hyasynth Biologicals Inc. (CA) 2023-09-27 EP disclosed
EP-4247955-A1 CANNABIDIOLIC ACID SYNTHASE VARIANTS WITH IMPROVED ACTIVITY FOR USE IN PRODUCTION OF PHYTOCANNABINOIDS Hyasynth Biologicals Inc. (CA) 2023-09-27 EP disclosed
US-20230272439-A1 METHOD FOR PRODUCING OLIVETOLIC ACID IN AN AMOEBOZOA HOST SPECIES LEIBNIZ-INSTITUT FÜR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE E. V. HANS-KNÖLL-INSTITUT (HKI) (DE) 2023-08-31 US disclosed
US-20230257787-A1 METHODS AND CELLS WITH MODIFYING ENZYMES FOR PRODUCING SUBSTITUTED CANNABINOIDS AND PRECURSORS HYASYNTH BIOLOGICALS INC. (CA) 2023-08-17 US disclosed
CN-116547263-A Methods and cells for producing substituted cannabinoids and precursors using modified enzymes 海牙森生物公司 2023-08-04 CN disclosed
CN-116529374-A Olive alkyd cyclase variants with improved activity for the production of phytocannabinoids 海牙森生物公司 2023-08-01 CN disclosed
EP-4185698-A1 METHODS AND CELLS WITH MODIFYING ENZYMES FOR PRODUCING SUBSTITUTED CANNABINOIDS AND PRECURSORS Hyasynth Biologicals Inc. (CA) 2023-05-31 EP disclosed
WO-2022016254-A1 METHODS AND CELLS WITH MODIFYING ENZYMES FOR PRODUCING SUBSTITUTED CANNABINOIDS AND PRECURSORS HYASYNTH BIOLOGICALS INC. (CA) 2022-01-27 WO disclosed
WO-2022003126-A1 METHOD FOR PRODUCING OLIVETOLIC ACID IN AN AMOEBOZOA HOST SPECIES LEIBNIZ-INSTITUT FÜR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE E. V. HANS-KNÖLL-INSTITUT (HKI) (DE) 2022-01-06 WO disclosed
US-11078502-B2 Method and cell line for production of polyketides in yeast HYASYNTH BIOLOGICALS INC. (CA) 2021-08-03 US disclosed
US-11078502-B2 Method and cell line for production of polyketides in yeast HYASYNTH BIOLOGICALS INC. (CA) 2021-08-03 US disclosed
US-10975395-B2 Method and cell line for production of polyketides in yeast HYASYNTH BIOLOGICALS INC. (CA) 2021-04-13 US disclosed
WO-2020232553-A1 METHODS AND CELLS FOR PRODUCTION OF PHYTOCANNABINOIDS AND PHYTOCANNABINOID PRECURSORS HYASYNTH BIOLOGICALS INC. (CA) 2020-11-26 WO disclosed
US-20200283807-A1 METHOD AND CELL LINE FOR PRODUCTION OF PHYTOCANNABINOIDS AND PHYTOCANNABINOID ANALOGUES IN YEAST HYASYNTH BIOLOGICALS INC. (CA) 2020-09-10 US disclosed
US-20200239916-A1 METHOD AND CELL LINE FOR PRODUCTION OF POLYKETIDES IN YEAST HYASYNTH BIOLOGICALS INC. (CA) 2020-07-30 US disclosed
US-20100311726-A1 REDUCTION OF BETA-AMYLOID LEVELS BY TREATMENT WITH THE SMALL MOLECULE DIFFERENTIATION-INDUCING FACTOR NIH - DEITR 2010-12-09 US disclosed
WO-2009011870-A1 REDUCTION OF BETA-AMYLOID LEVELS BY TREATMENT WITH THE SMALL MOLECULE DIFFERENTIATION-INDUCING FACTOR THE GENERAL HOSPITAL CORPORATION (US) 2009-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10975395-B2 Method and cell line for production of polyketides in yeast DTYMK, PDXK, PANK2 ALOX5 1510/4885TYR 2511/4885MEN1 1721/4885
US-20230257787-A1 METHODS AND CELLS WITH MODIFYING ENZYMES FOR PRODUCING SUBSTITUTED CANNABINOIDS AND PRECURSORS ENGASE, CNR1, CNR2 ALOX5 587/4885TYR 1112/4885MEN1 3969/4885
US-11078502-B2 Method and cell line for production of polyketides in yeast DTYMK, PDXK, PANK2 ALOX5 1510/4885TYR 2511/4885MEN1 1721/4885
US-20200239916-A1 METHOD AND CELL LINE FOR PRODUCTION OF POLYKETIDES IN YEAST DTYMK, PDXK, PANK2 ALOX5 1510/4885TYR 2511/4885MEN1 1721/4885
US-20100311726-A1 REDUCTION OF BETA-AMYLOID LEVELS BY TREATMENT WITH THE SMALL MOLECULE DIFFERENTIATION-INDUCING FACTOR APP, BACE1, APBA1 ALOX5 2214/4885TYR 4702/4885MEN1 2128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.